Table 1 Baseline characteristics at discharge between the control and usual care groups
Overall (n = 277) | Usual care (n = 133) | Intervention (n = 144) | P value | |
|---|---|---|---|---|
Age (years) | 74 ± 13 | 74 ± 13 | 75 ± 13 | 0.657 |
Male (%) | 59.6 | 58.6 | 60.4 | 0.764 |
Ischemic heart disease (%) | 36.5 | 33.1 | 39.6 | 0.261 |
NYHA class III/IV (%) | 10.5 | 9.0 | 11.8 | 0.450 |
Prior HF admission (%) | 22.4 | 21.1 | 23.6 | 0.610 |
LVEF (%) | 45.4 ± 16.0 | 44.9 ± 16.5 | 45.9 ± 16.2 | 0.624 |
HFpEF (LVEF ≥ 45 %) (%) | 46.6 | 42.9 | 50.0 | 0.234 |
Vital sign | ||||
SBP (mmHg) | 118 ± 22 | 117 ± 23 | 119 ± 21 | 0.586 |
Heart rate (beats/min) | 68 ± 12 | 69 ± 13 | 68 ± 10 | 0.623 |
Comorbidity condition | ||||
Hypertension (%) | 58.5 | 52.6 | 63.9 | 0.057 |
Atrial fibrillation (%) | 41.9 | 44.4 | 39.6 | 0.421 |
Diabetes (%) | 37.5 | 38.3 | 36.8 | 0.784 |
Dyslipidemia (%) | 27.1 | 26.3 | 27.8 | 0.784 |
COPD (%) | 9.0 | 9.0 | 9.0 | 0.999 |
Laboratory values | ||||
Hemoglobin (g/dl) | 11.7 ± 2.3 | 11.8 ± 2.3 | 11.6 ± 2.4 | 0.482 |
Sodium (mEq/dl) | 137.8 ± 4.0 | 138.0 ± 4.2 | 137.6 ± 3.8 | 0.394 |
BUN (mg/dl) | 34.1 ± 20.6 | 33.4 ± 21.1 | 34.8 ± 20.1 | 0.577 |
Creatinine (mg/dl) | 1.49 ± 1.19 | 1.48 ± 1.34 | 1.50 ± 1.04 | 0.874 |
eGFR (ml/ml/1.73 m2) | 48.3 ± 29.1 | 49.2 ± 27.4 | 47.5 ± 30.7 | 0.631 |
BNP (pg/ml)* | 325 ± 395 | 360 ± 435 | 306 ± 372 | 0.366 |